Updated 1/30/23
In order to provide complete transparency to our members, I have created this document, which is available to the public, to address any concerns about potential conflicts of interest.
Since 2014, I have been covering the cannabis sector and have worked in several capacities with public and private companies. In order to provide our subscribers with an unbiased platform, I have sold all of my positions in cannabis stocks and will not invest in publicly-traded cannabis stocks. While this may disappoint to some of you, my intent is to avoid anything that could affect my objectivity.
Given my background in the cannabis industry, I closely follow cannabis stocks and conduct thorough research on the companies we cover. My investors relations experience has greatly improved my understanding of the cannabis sector. Specifically, I know if a company is conducting a marketing/investor relations campaign and will be able to provide insight on these types of operators. Due to this, our readers will better understand why a stock is trending higher as we will highlight the companies that are engaging investor relations service providers.
In late 2016, I started to work with cannabis companies and provided investor relations services to many public and private companies. Currently, we work with a few companies in a consulting or investor relations capacity. In order to provide the best service, I do not plan to cover any companies that I have agreements with. At this time, I am working with the following companies: Cannara Biotech, Body and Mind, and Heritage Cannabis. If we sign a new client, our readers will be the first to know and we will immediately update our disclosures and stop covering such company on this platform.
As I have previously indicated, if I enter into any consulting arrangements with private companies, ...
